Related Experiment Video
Updated: Sep 5, 2025
06:32
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
5.3K
A Novel Overall Survival Prediction Signature Based on Comprehensive Research in Prostate Cancer Bone Metastases
Konghe Hu1, Xinyue Hu2, Yang Duan3
1Department of Spine Surgery, The Affiliated Yuebei People's Hospital of Shantou University Medical College, Shaoguan, China.
Frontiers in Medicine
|July 5, 2022
Summary
Researchers identified six genes, including ISLR, linked to prostate adenocarcinoma bone metastases. These genes show prognostic value and could lead to new diagnostic biomarkers and therapeutic targets for this condition.
Area of Science:
- Oncology
- Genomics
- Biomarker Discovery
Background:
- Prostate adenocarcinoma (PRAD) bone metastases cause significant morbidity and mortality.
- Effective diagnostic biomarkers for PRAD bone metastases are currently lacking.
- This study aimed to identify novel biomarkers and prognostic indicators for PRAD bone metastasis.
Purpose of the Study:
- To identify key genes associated with PRAD bone metastasis.
- To evaluate the prognostic value of identified genes.
- To explore potential diagnostic biomarkers and therapeutic targets for PRAD bone metastasis.
Main Methods:
- Integrated analysis of The Cancer Genome Atlas (TCGA) and PRAD SU2C 2019 datasets.
- Gene ontology and gene set enrichment analyses for biological functions.
- Protein-protein interaction network construction and validation using ROC and Kaplan-Meier curves.
Main Results:
- Six genes (DDX47, PRL17, AS3MT, KLRK1, ISLR, S100A8) were identified with prognostic value for PRAD bone metastasis.
- Enrichment analysis revealed associations with extracellular matrix, steroid hormone response, and detoxification pathways.
- A predictive model demonstrated high accuracy (AUC > 0.89) for overall survival prediction.
Conclusions:
- ISLR was identified as a potential biomarker for PRAD bone metastasis.
- The identified prognostic genes may serve as therapeutic targets for PRAD bone metastasis.
- S100A8 expression is specific to PRAD and absent in normal prostate tissue, suggesting its diagnostic potential.
